Candel Therapeutics (CADL) Change in Cash: 2020-2023
Historic Change in Cash for Candel Therapeutics (CADL) over the last 3 years, with Dec 2023 value amounting to -$7.6 million.
- Candel Therapeutics' Change in Cash rose 58.77% to -$7.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$34.6 million, marking a year-over-year decrease of 171.90%. This contributed to the annual value of $67.2 million for FY2024, which is 294.09% up from last year.
- Per Candel Therapeutics' latest filing, its Change in Cash stood at -$7.6 million for Q4 2023, which was up 15.05% from -$8.9 million recorded in Q3 2023.
- Over the past 5 years, Candel Therapeutics' Change in Cash peaked at $64.1 million during Q3 2021, and registered a low of -$18.4 million during Q4 2022.
- Moreover, its 3-year median value for Change in Cash was -$6.6 million (2021), whereas its average is $30,000.
- Per our database at Business Quant, Candel Therapeutics' Change in Cash soared by 2,964.06% in 2021 and then slumped by 645.02% in 2023.
- Quarterly analysis of 4 years shows Candel Therapeutics' Change in Cash stood at $16.8 million in 2020, then crashed by 134.19% to -$5.7 million in 2021, then tumbled by 219.73% to -$18.4 million in 2022, then spiked by 58.77% to -$7.6 million in 2023.
- Its Change in Cash stands at -$7.6 million for Q4 2023, versus -$8.9 million for Q3 2023 and -$7.4 million for Q2 2023.